Source: PR Newswire Crown Laboratories, ("Crown"), a leading, fully integrated, global skincare company and a Hildred Capital Management LLC ("Hildred") portfolio company, and L Catterton, the largest global consumer-focused private equity firm, today announced that they have entered into a definitive agreement under which Crown will acquire StriVectin. The transaction is expected…...